GPCR - Wall Street Estimates - Structure Therapeutics Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 27.06

0.296 %

$ 1.55 B

Market Cap

-12.53

P/E

Price Target Average

241.46%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

25.99%

Net Income Estimate

3.32%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Structure Therapeutics Inc.

Wall Street analysts predict an average 1-year price target for GPCR of $92.4 , with forecasts ranging from a low of $65 to a high of $118 .

GPCR Lowest Price Target Wall Street Target

65 USD 140.21%

GPCR Average Price Target Wall Street Target

92.4 USD 241.46%

GPCR Highest Price Target Wall Street Target

118 USD 336.07%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free